Core Insights - *ST Huaron (600421.SH) released its semi-annual report for 2025 on August 28, 2025, indicating significant institutional investment in the company [1] Institutional Holdings - As of August 27, 2025, three institutional investors disclosed their holdings in *ST Huaron A-shares, totaling 96.7525 million shares, which represents 49.46% of the total share capital of *ST Huaron [1] - The institutional investors include Zhejiang Hengshun Investment Co., Ltd., Wuhan New Generation Technology Co., Ltd., and Shanghai Tianji Investment Co., Ltd., with a combined holding ratio of 49.46%, remaining unchanged [1]

股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-053 湖北华嵘控股股份有限公司 1 合伙）作为收购方应当编制《详式权益变动报告书》，聘请财务顾问并出具核查 意见。截至目前，收购方伯程汇能的《详式权益变动报告书》尚未编制完成，尚 未出具财务顾问核查意见。由于《监管工作函》涉及的部分资料需要完善，公司 将再次延期回复《监管工作函》，预计不晚于 2025 年 9 月 4 日提交回复公告，及 时履行信息披露义务。 公司将积极督促相关方尽快完成《监管工作函》的回复工作并及时履行信息 披露义务。公司指定信息披露媒体和网站为《证券时报》《中国证券报》及上海 证券交易所网站 www.sse.com.cn），有关信息以公司在上述指定媒体和网站披露 的信息为准，敬请广大投资者理性投资，注意投资风险。 关于延期回复上海证券交易所《监管工作函》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要提示： 根据公司控股股东浙江恒顺投资有限公司（以下简称"浙江恒顺"）及其一 致行动人上海天纪投资有限公司（以下简称"上海 ...

Group 1 - The company *ST Huaron held its ninth board meeting on August 26, 2025, in Wuhan, discussing the proposal for the write-off of certain accounts receivable and other receivables [1] - The meeting was conducted in a hybrid format, combining in-person and communication methods [1] Group 2 - The news highlights a significant advancement in the field of genetic engineering, with the world's first successful transplantation of gene-edited pig lungs into a human [1] - The article includes a dialogue with key participants regarding the timeline for clinical applications of this breakthrough [1]

Core Points - *ST Huahong reported a significant decrease in the number of shareholders, with a total of 7,887 as of June 30, 2025, down by 11,265 or 58.82% from March 31, 2025 [1][2] - The average number of shares held per shareholder increased from 10,200 to 24,800, with an average market value of 172,600 yuan [1][2] - Compared to the general equipment industry, *ST Huahong's shareholder count is below the industry average of 29,200 as of June 30, 2025, and its average market value is also lower than the industry average of 195,700 yuan [1][2] Financial Performance - From March 31, 2025, to June 30, 2025, *ST Huahong's stock price increased by 3.88%, despite the significant reduction in shareholder numbers [1][2] - During this period, the net outflow of funds from major investors was 3.3497 million yuan, while retail investors saw a net inflow of 1.516 million yuan [2]

Group 1 - The board of directors of Hubei Huaron Holdings Co., Ltd. held its fourth meeting of the ninth session on August 26, 2025, with all seven directors present and participating in the voting [1] - The meeting approved the 2025 semi-annual report and summary, which had previously been reviewed by the board's audit committee [1] - The voting results for the semi-annual report were unanimous, with 7 votes in favor and no votes against or abstentions [1] Group 2 - The board also approved a proposal regarding the write-off of certain accounts receivable and other receivables from subsidiaries, which had been fully provisioned for bad debts [2] - The write-off is stated to accurately reflect the company's financial status and complies with relevant accounting standards and internal financial management policies [2] - The proposal regarding the write-off received unanimous approval, with 7 votes in favor and no votes against or abstentions [2]

Group 1 - The company held the third meeting of the ninth supervisory board on August 26, 2025, via communication methods, with all three supervisors present and voting [1][2] - The supervisory board approved the 2025 semi-annual report, affirming that the information accurately reflects the company's operational management and financial status for the first half of 2025 [1][2] - The board also approved a proposal regarding the write-off of certain receivables and other receivables, confirming that these have been fully provisioned for bad debts and will not impact the current or previous financial results [2]

一、审议并通过了《2025 年半年度报告及摘要》。公司监事会认为： 1、公司 2025 年半年度报的编制和审议程序符合法律、法规、公司章程的各 项规定； 2、公司 2025 年半年度报的内容和格式符合中国证监会和上海证券交易所的 各项规定，所包含的信息真实地反映了公司 2025 年 1-6 月的经营管理和财务状 况等事项； 3、在提出本意见前，公司监事会未发现参与半年报编制和审议的人员有违 反保密规定的行为。 证券代码：600421 证券简称：*ST 华嵘 公告编号：临 2025-051 湖北华嵘控股股份有限公司 第九届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北华嵘控股股份有限公司（以下简称"公司"）第九届监事会第三次会议 于 2025 年 8 月 26 日下午 15:30 以通讯方式召开，本次会议通知已于 2025 年 8 月 14 日以短信、电话、邮件、通讯等方式通知全体与会人员。会议应到监事 3 人，实际表决监事 3 人，会议的召开符合《公司法》和《公司章程》的有关规定。 会议由 ...

湖北华嵘控股股份有限公司 2025 年半年度报告 .公司代码：600421 公司简称：*ST 华嵘 湖北华嵘控股股份有限公司 2025 年半年度报告 1 / 135 湖北华嵘控股股份有限公司 2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人周梁辉、主管会计工作负责人闻彩兵及会计机构负责人（会计主管人员）闻 彩兵声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告包含若干公司对未来发展战略、业务规划、经营计划等前瞻性陈述。这些陈述乃基于 当前能够掌握的信息与数据对未来所做出的估计或预测，不构成公司对投资者的实质承诺，敬请 投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 ...

股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-052 湖北华嵘控股股份有限公司 关于子公司核销部分应收账款及其他应收款的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 四、公司董事会意见 湖北华嵘控股股份有限公司（以下简称"华嵘控股"或公司）于 2025 年 8 月 26 日召开了第九届董事会第四次会议和第九届监事会第三次会议，审议通过 了《关于公司子公司核销部分应收账款及其他应收款的议案》，为客观、公允地 反映公司的资产、财务状况及经营成果，根据《企业会计准则》及公司财务管理 制度的相关规定，结合公司实际情况，公司子公司浙江庄辰建筑科技有限公司（以 下简称"浙江庄辰"）对部分无法收回、已全额计提坏账准备的应收账款及其他 应收款进行核销，现将相关事项公告如下： 根据《企业会计准则》《上海证券交易所股票上市规则》和公司财务管理制 度的相关规定，为真实、准确地反映公司资产、财务状况及经营成果，公司及子 公司浙江庄辰决定对部分无法收回、已全额计提坏账准备的应收账款及其他应收 款进行核销。本次核销的 ...

Core Viewpoint - The acquisition of 25.01% of shares in Hubei Huaron Holdings Co., Ltd. by Hainan Bocheng Huineng Technology Center (Limited Partnership) is facing significant uncertainty due to the lack of prepared funds and incomplete required documentation [2][3]. Group 1: Acquisition Details - Hainan Bocheng Huineng is required to pay a cash consideration of 450.4129 million yuan for the acquisition [2]. - The acquisition is contingent upon the completion of a detailed equity change report and the hiring of a financial advisor, which have not yet been fulfilled [2][3]. Group 2: Regulatory Compliance - The company received a regulatory letter from the Shanghai Stock Exchange regarding the transfer of control and is actively working with the acquirer to address the issues raised [3]. - The acquirer has requested an extension to respond to the regulatory letter due to the need for additional documentation [3]. Group 3: Information Disclosure - The company is committed to timely information disclosure and has designated specific media outlets for announcements [3]. - Investors are advised to stay informed through the designated media and exercise caution regarding investment risks [3].